Brii Biosciences
Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.
Business Model:
Revenue: $0
Employees: 51-200
Rankings
Industries / Tags:
Detailed Brii Biosciences Information
Geographic Data
Address: 110 Corcoran Street, Office 05-130
City: Durham
State: NC
Zip: 27701
Country: US
Financial Info
Stage:
Raised Last:
$155M
Raised Total:$415M
Social
Linkedin
Crunchbase
Metrics
4,424,445Website Global Rank
2,231Website Monthly Traffic
Twitter Followers
Description
Brii Biosciences is a developer of bio-pharmaceutical medicines intended to provide medical solutions to Chinese patients to fulfill their health and treatment needs. The company&s;s medicines focuses on infectious disease drug development and commercialization in China and leverage technology and data to drive improvements to the Chinese healthcare system and outcomes for patients, enabling patients to get access to better treatments and cures for life-threatening diseases.
Contact Phone:
Contact Email:
Brii Biosciences went public on 7/16/2021 on the HKG
Listed Exchange:
HKG
IPO Date:
7/16/2021
IPO Valuation:
$2B
Ticker Symbol:
2137
IPO Price:
$2.8643520127705044/share
Amount Raised:
$319M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 11/2019 | AN2 Therapeutics | Series A | 0 |
| 6/2019 | Artizan Biosciences | Series A | 0 |
| 11/2019 | AN2 Therapeutics | Series A | 0 |
| 6/2019 | Artizan Biosciences | Series A | 0 |
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
